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ABSTRACT The current model does not account adequately for the characteristics of miniature endplate currents (MEPCs).
We do not understand their relatively slow rise, the shape of their rise, their variable and sometimes prolonged decay, and
the correlation between amplitude and decay time. If we assume that ACh is released from the vesicle through a pore and
that the vesicle enlarges as it takes on additional transmitter, the predictions are more like MEPCs. However, previous
measurements showed that after quantal size was increased the vesicles in the terminal were not enlarged. This need not be
a problem, because some of the ACh is added to vesicles positioned at the active zones, a process known as second-stage
loading. By using the false transmitter precursor monoethylcholine we provide additional evidence for second-stage loading.
The distribution of quantal sizes at the junction usually does not follow a normal probability distribution; it is skewed to the
right. The skew can be accounted for by a model incorporating second-stage loading in which the vesicles are released
randomly, without regard to their ACh content. If the vesicles increase in size when they contain more transmitter, only
vesicles at the active zone need swell.
INTRODUCTION
Because quanta are the units that underlie synaptic trans-
mission, it is scarcely surprising that currently there is much
interest in neurotransmitter quanta in the central nervous
system (reviewed by Edwards, 1995). Quanta were first
discovered at the frog neuromuscular junction, where the
miniature endplate currents (MEPCs) they produce can be
measured with the two-electrode voltage clamp or by an
extracellular electrode (Katz, 1969). The MEPCs are almost
invariably cited as the models to which other synaptic
responses are compared.
The classic picture of MEPC generation has been
quantitatively modeled by a number of investigators
(Wathey et al., 1979; Rosenberry, 1979; Madsen et al.,
1984; Salpeter, 1987; Nigmatullin et al., 1988; Parnas et
al., 1989; Bartol et al., 1991). They assume that the ACh
is released instantaneously from the nerve terminal, pre-
sumably as the synaptic vesicle abruptly dumps its con-
tents by exocytosis. Then they calculate the diffusion of
the ACh in the cleft, its interaction with the endplate
receptor (AChR), followed by the opening of the chan-
nels in the receptor, the hydrolysis of the ACh by ace-
tylcholinesterase (AChE), and the closing of the chan-
nels. These models are feasible because there are good
measurements of the density of AChR and AChE in the
synaptic cleft, and of the kinetics of their reactions with
ACh (Salpeter, 1987). The usual MEPC is due to the
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opening of 1000-2000 ion channels in the AChR in the
endplate membrane. Two thousand AChRs lie within a
0.23-,um radius from the point of release. The ACh can
diffuse to these 2000 receptors in less than 50 ,us. The
models suggest the ACh concentration in the cleft drops
rapidly, as transmitter is bound to AChR and destroyed
by AChE. By the time the peak number of endplate
channels has opened, the ACh concentration falls to such
a low level that few more channels are opened. Conse-
quently, the decay of the MEPC is determined by the
random closings of the receptor channels, which have a
mean open time of about 1000 ,us.
This classical model accounts reasonably well for most of
the features of MEPCs in untreated preparations-hence it
has been widely accepted for more than 20 years (Magleby
and Stevens, 1972; Edmonds et al., 1995). We first became
concerned about the model when we studied the large
MEPCs observed after treatments that increase quantal size
(Van der Kloot and Van der Kloot, 1986; Van der Kloot,
1987, 1991b). Many of the large MEPCs clearly have longer
rise times and slower decays than predicted by the model.
Gradually we came to realize that MEPCs from untreated
preparations may share the same discrepancies. We will
document these discrepancies with results from the litera-
ture and with new experiments. Then we will suggest how
the classical model can be modified to account for the
observations.
Another question about MEPCs is the distribution of their
sizes. They usually do not follow a normal probability
distribution function; instead their distribution is skewed to
the right (Van der Kloot, 1987, 1989, 1991a,b). The skew-
ing is particularly noticeable after quantal size has been
enlarged. We will also present a hypothesis to account for
the skewing ofMEPC sizes and suggest how this model can
be tested.
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MATERIALS AND METHODS
Data recording
MEPCs were recorded from junctions in the frog, Rana pipiens, in sartorius
or cutaneous pectoris muscles. The preparations were in a Ringer's that
contained (in mM): NaCl, 120; KCl, 2.0; CaC12, 2.5; and N-tris-(hydroxy-
methyl) methyl-2-aminoethanesulfonic acid/NaOH (TES), 4.0 at pH 7.4. In
hypertonic gluconate solution the NaCl was replaced with 200 mM Na
gluconate.
The methods for preparing the electrodes, performing the two-electrode
voltage clamp, and capturing the data on a computer are given by Van der
Kloot et al. (1994). The methods for recording the extracellular miniature
endplate potentials (MEPPs) are given by Van der Kloot (1995). However, we
no longer use a digital delay. Instead, the recordings were obtained using a
DAS16/330 A/D converter from ComputerBoards (Mansfield, MA), which
can be programmed to store a predetermined number of samples before and
after a trigger pulse. This eliminates the need for a digital delay. The software
sampling routines were also from ComputerBoards. The programming was
done in Turbo Pascal. There is a problem with the system when the board is
programmed to take in a series of sweeps: on occasion it freezes. By chance
we found that the program will resume if the operator keys in a "break"
followed by a "control-break." The differentiation was done by a numerical
method (Stavitzy and Golay, 1964).
Modeling
We used the model of MEPC generation developed by Wathey et al.
(1979). In this model the ACh simply diffuses in circular coordinates from
the point of release. There are more geometrically accurate models (Mad-
sen et al., 1984; Nigmatullin et al., 1988; Parnas et al., 1989). The most
comprehensive model uses Monte Carlo methods to follow individual ACh
molecules diffusing in three dimensions in a much more realistic geometry
(Salpeter, 1987; Bartol et al., 1991). But there seems to be little difference
in the predictions of the simple and the more complex models. The values
for the parameters come from Wathey et al. (1979); they are given in
parentheses when the parameters are defined. In the model a quantum of
ACh (10,000 molecules) is released from the terminal at a point facing the
center of a circular endplate. The ACh is distributed over a circle with the
radius of a synaptic vesicle (0.025 ,um), with the highest concentration in
the center of this circle and with the concentration declining toward the
edge (in an approximation to a gaussian). The [ACh] in the cleft is
abbreviated as a. The radial coordinate r (0.5 ,um) is the distance from the
center of the cleft to its edge. At the edge the cleft is open to the external
solution. Diffusion of a from the points of release is given by
Sa l82a I Sa\
St]diffusion r+ 8 (1)
where D is the diffusion coefficient for ACh (3 x 10-6 cm2 s- ). If AChE
is present the rate of ACh hydrolysis is given by
a A
_]bydrolysis = -kl(eo - eA)a, (2)
where kI is the binding constant (2 X 108 M- 1 s '), e. (2,600 sites/(,um2))
is the concentration of AChE, and eA is the concentration of AChE that has
bound an ACh:
-eA A) A,
k1(e. e) k3eA
where k3 is the turnover rate (1.6 X 104 s- '). The binding of ACh to AChR
is given by
,Jrecptors= -2k+1(co- c - c")a (4)+t receptors
- k+2C'a + k-Ic' + 2k-2C" ,
(3)
where k+1 is the binding rate ofACh to the unoccupied receptor (1.5 X 108
M-' s-)), k_ is the disassociation rate of ACh from the singly occupied
receptor (7.5 x 10 3 s-'), k+2 is the binding rate of ACh to the singly
occupied receptor (3 x 10 7 M-l s-1), k_2 iS the dissociation rate of ACh
from the doubly occupied receptor, co is the concentration of AChR
(12,000/pLm2), cl is the concentration of singly occupied receptor, and cl'
is the concentration of doubly occupied receptor
= 2k+1(co - cl-c)a + 2k-2cl- K+2c1a -k cSt
(5)
- = k+2c1a - 2k2cI . (6)
We also calculated the rate of channel opening, &han/&t:
&han
at= k+2c"la.
The equations for diffusion were replaced with finite difference approx-
imations for radial coordinates. The simultaneous equations were solved by
the Runge-Kutta-Fehlberg method, which estimates the truncation error at
each step, so that the time step could be adjusted to keep within a
predetermined error. Calculations began with a temporary synaptic radius
of twice the vesicle diameter, so that Sr was small, and then as the ACh
diffused outward, Sr was increased stepwise until it reached the full radius
of the cleft.
We calculated the effects of release through a pore by combining Eq. 8
(given in the Results) with the Wathey et al. (1979) model (Van der Kloot,
1995). The pore length was 1 X 10-6 cm, and the diffusion coefficient for
ACh in the vesicle and pore was 4 x 10-6 cm2 s-'. When the quantum
contained 10,000 ACh molecules the vesicle volume was 2.65 x 10-17
cm3. In a variation of this model, as the ACh content was varied, the vesicle
volume was changed to keep the ACh concentration in the vesicle constant.
The pore radius was 0.08 X 10-6 cm.
We modeled the open time of an endplate AChR by -ln(rd), where rd
is a random number between 0 and 1. This step was repeated 1000 times,
and the resulting array of open times was sorted in ascending order. The
open time of the 500th event was taken as the tl,2 of the model MEPC. This
sequence was repeated 100 times, to give the range of values expected in
one data set. We continued the process until we had accumulated 100
model data sets.
We modeled the effects by second-stage loading on the size distribution
of MEPCs as follows. The vesicles first acquired ACh in the cytoplasm by
a gaussian process that gave them a mean content with a CV of 10%. They
then were attached to the active zones. With each time step a randomly
selected fraction of those on active zones were released, those remaining on
the active zone each received a gaussian addition of ACh (CV = 10%). The
empty positions on the active zone acquired vesicles from the cytoplasm.
The rate of ACh addition at the active zones was varied so that the mean
amount added reached the desired level. This was done empirically, by
selecting a rate of second-stage loading, running the model until the size of
the quanta released arrived at an asymptote, and then modifying the rate
until the model produced the required mean quantal size.
RESULTS
The shape of the rise of the miniatures
The rise times of frog MEPCs and of MEPPs recorded with
an extracellular electrode appear to be slower than predicted
by the classical model (Dwyer, 1981; Van der Kloot, 1995).
The rate of rise of the MEPC might be slower than predicted
because the ACh is released from the vesicle through a
narrow pore, or because it takes time for the cationic ACh
(7)
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to dissociate from anions in the vesicle wall or interior
(Nanavati and Fernandez, 1993). There is substantial evi-
dence that release from mast cells and adrenal chromaffin
cells is through a pore (Spruce et al., 1990; Monck and
Fernandez, 1992; Chow et al., 1992).
Further evidence comes from an examination of the shape
of the rise of the endplate current and its differential, be-
cause predictions of the classical model and the pore model
are quite different. The classical model predicts that chan-
nels will open most rapidly at the beginning, and that the
rate of opening will fall off progressively as the MEPC rises
(Fig. 1 A). The pore model predicts that the rise will be
sigmoid, with the rate of channel opening rising and then
decreasing during the upstroke of the MEPC (Fig. 1 B).
Recordings of rise times with extracellular electrodes show
that their shapes resemble the predictions of the pore model
and are quite different from the predictions of the classic
model (Fig. 1 C). The record shown is typical of the 47
externals from five junctions that were examined.
The variance of the decay times
Previous work with preparations in which quantal size was
experimentally enlarged showed that decay times are often
much longer than predicted by the closing times of the
endplate channels (Van der Kloot, 1991b). The present
experiments suggest that for many MEPCs in untreated
preparations the decay times also do not fit the predictions.
An example of the output of the classical model of Wathey
et al. (1979) is shown in Fig. 2 A, along with a real MEPC
from an untreated preparation. To make comparisons by eye
easier, the model MEPC was normalized so that its peak
inward current was the same as the real MEPC. Obviously
the model in the figure decays much faster than the MEPC.
The discrepancy occurs because we selected one of the
longest MEPCs from a set of 121 recorded at the same
junction. Fig. 2 B illustrates some of the variation seen in
the MEPCs in this set. If we had chosen one of the shorter
MEPCs in the set, its decay would be fit well by the model.
Fig. 2 C shows the variation in decay times seen in a typical
data set. The points are plotted on a probability scale, which
is used because the points fall along a straight line if they
follow a normal probability distribution function (Sokal and
Rohlf, 1981; Van der Kloot, 1989). The variance of the data
is proportional to the slope of the line. The decay times in
Fig. 2 C do not fall along a line, but on an ascending curve,
which means that when plotted as a histogram the bins
would be skewed to the right. This skewing is also typical
of plots of MEPC amplitudes or areas (Van der Kloot and
Van der Kloot, 1986; Van der Kloot, 1989, 1991b). We will
return to the problem of the skewing later.
We would expect some variation in the decay times
within a set because the ACh opens a large number of
channels with random, exponentially distributed lifetimes.
Such random variations lead to scatter in the decay times of
the MEPCs, which can be easily modeled, as is also shown
in Fig. 2 C. With 1000 channels opening, the coefficient of
variation (CV) of modeled half decay times was 0.04 ±
0.0054 (SD). We did not include in this calculation the
additional variance expected from the jitter in the rise times,
because Monte Carlo modeling suggests that it is negligible
(see figure 4 in Anglister et al., 1994). The variation is much
less than predicted for central synapses, where fewer trans-
mitter molecules are in each quantum (Faber et al., 1992).
The variance in the decay times from real MEPCs is higher
than predicted by the model. From 133 sets of measure-
ments with the two-electrode voltage clamp on the frog
cutaneous pectoris muscle (each set containing about 100
MEPCs), the mean CV was 0.17 ± 0.032, more than four
times higher than the model predicts. The probability that
the differences between the CVs of the model and the data
is by chance is < 10-6. From six sets of measurements with
extracellular electrodes, which have less instrumental noise,
the mean CV was 0.14 ± 0.035. The classical model does
not account for the observed scatter of the decay times. At
the frog neuromuscular junction there is no evidence for
different receptor types, with different mean open times
B. 1 OOt
80(
c0)a.
0
U,
0
C
c
cis
C.
60C
40C
20C
0 0.05 0.1 0.15 0.2 0.25
ms
,'d(channals)/dt ,
9/rvD
.p.
D /
, Channels
0 0.2 0.4 0.6
2C.
> 1.5
> 1
Ec
0
30.5
0
ms
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FIGURE 2 Properties of MEPCs compared to model MEPCs. (A) .... An MEPC recorded from an untreated frog sartorius muscle clamped at -80 mV
at 22.3°C. This MEPC was one of the longest in the data set. , A modeled MEPC. (B) Some of the variety of MEPCs recorded in the same set. (C)
Plots of actual and modeled half decay times on a probability abscissa. Data fitting a normal probability distribution function falls along a straight line when
plotted on a probability abscissa. The plot shows that the half decay times of MEPCs are not normally distributed. The sizes of the MEPCs also do not
fit well to a normal distribution (Van der Kloot, 1991b). 0, The half-times of MEPC decays from the data set. *, The distribution of half-times predicted
by a model in which the decay is determined solely by the open time of endplate channels. (D) Dense line, Averaged MEPCs from a preparation pretreated
with 1 ,uM PGE2, -80 mV, 20.20C. Light line, A calculated MEPC, in which the number of AChs released was increased so that roughly the same number
of channels were opened by the MEPC and the model, i.e., their areas are equal. (E) MEPCs from a set recorded from a sartorius muscle soaked for 2 h
in Ringer's in which the NaCl was replaced with 200 mM Na gluconate. The recording was done in Ringer's at -80 mV at 22.3°C. This was the
contralateral muscle from that used for the recordings shown in Fig. 1 A. (F) A plot of the t112s of 198 MEPCs from a junction in a muscle pretreated in
gluconate solution as a function of their amplitudes. The recording was done at -100 mV at 22.3°C. For the regression line R2 = 0.92. The fitting of the
regression line was constrained to run through 0, 0.
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(Edmonds et al., 1995). Therefore it is unlikely the scatter is
caused solely by postsynaptic diversity.
Other evidence in the literature supports the conclusion
that MEPC decay in normal preparations can be slower than
predicted from channel closings. The mean open time for
the endplate channels is obtained from measurements of the
endplate current fluctuations recorded during the sustained
application of ACh (Anderson and Stevens, 1973). Since the
fluctuation method was developed it has been found that
often the open period of the endplate channels is interrupted
by very brief closings. Such closings will not substantially
alter the power spectra of the ACh fluctuations (Edmonds et
al., 1995). The decay of averaged MEPCs is slower than
predicted by the measurements of channel mean opening
time in toad, frog, and human muscle (Colquhoun et al.,
1977; Gage and Van Helden, 1979; Katz and Miledi, 1973;
Cull-Candy et al., 1979). Previously we recorded MEPCs
and then used the fluctuation method to determine the mean
channel conductances and open times on the same fibers
(Van der Kloot et al., 1994). Then we employed a decon-
volution method to calculate when individual channels
would have to open to generate individual or averaged
MEPCs (Cohen et al., 1981). Frequently the results showed
that the initial surge of channel opening was followed by a
tail of continued opening. This tail accounts for the length-
ening of the MEPC decay.
Decay times of large quanta
There is an even greater discrepancy between the classical
model and MEPCs recorded from preparations treated to
increase quantal size. Size can be increased by activating
protein kinase A, either with permeable cAMP derivatives
or epinephrine, or by soaking in hypertonic solutions (Van
der Kloot and Van der Kloot, 1986; Van der Kloot, 1987,
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1991b; Van der Kloot and Branisteanu, 1992). Size can also
be increased by insulin or by PGE2, working by intracellular
signaling pathways yet to be identified. Size increases be-
cause more ACh is released per quantum. As shown in Fig.
2 D the discrepancy between the classical model and the
decay of MEPCs is even more striking when the quanta
contain more ACh. In this example the model was scaled so
that it opened the same number of channels as the MEPC.
Fig. 2 E shows examples of the variations in MEPC shape
seen after quantal size was increased by soaking in hyper-
tonic Na gluconate solution. For reasons we do not yet
understand, this treatment produces the largest increases in
size; the mean increase is almost fourfold (Van der Kloot,
1987). These exceptionally large MEPCs illustrate force-
fully the problems faced by the classical model. In the
classical model, when more ACh is released, the MEPC
amplitude increases, the rise time is lengthened, but decay is
still determined by the mean channel open time. In reality
there is significant correlation between MEPC amplitudes
and decay times: the larger the amplitude, the slower the
decay (Fig. 2 F). This correlation was observed in scores of
examples, regardless of whether the regression line was
constrained to pass through 0,0. Deconvolutions of the
enlarged MEPCs show that channels continue to open for 10
ms or even longer (see Van der Kloot, 1991b, figure 20).
Modifying the model to account for the relation
between amplitude and decay time
The correlation of amplitude and decay time is not predicted
by either the classical or the pore model (Fig. 3 A shows the
classical model). Release through a pore will slow MEPC
rise and decay times. However, it does not predict that the
decay time will lengthen when the concentration of ACh in
B. 6000
5000
ca)
r-
0
0CO)
c
cu
(a
4000
3000
2000
1000
00 2 4 6 8 10
ms
0 2 4 6 8 10
ms
FIGURE 3 Model MEPCs calculated by the classical model of Wathey et al. (1979) with different quantities of ACh in the quanta. (A) The model in
which all of the ACh is released at time 0. (B) The ACh is released from a vesicle through a pore according to Eq. 1. Values used: r. = 0.08 X 10-6 cm;
L = 1 X 10-6 cm; D = 4 X 10-6 cm2 s-1. When the quantum contained 10,000 ACh molecules the vesicle volume was 2.65 x 10l-7 cm3. As the ACh
content was varied, the vesicle volume was changed to keep the ACh concentration in the vesicle constant.
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the vesicle is increased. The amount released from the
vesicle, cr, in time t is described by
Cr= Co{I - exp(v (m.D)}. (8)
where C. is the amount initially in the vesicle, V is the
vesicular volume, L is the length of the pore, ro is the radius
of the pore, and D is the diffusion coefficient for the ACh in
the pore (Almers et al., 1991). The efflux is proportional to
C., but an increase in CO does not extend the period of
release.
Suppose, however, that the vesicles enlarge as they are
loaded further, so their concentration of ACh does not
increase but their volume (V in Eq. 8) increases. When a
pore opens between the vesicle interior and the synaptic
cleft, the duration of ACh efflux depends upon the volume
of the vesicle: the larger the vesicle, the longer the period of
efflux and the slower the decay of the MEPC (Fig. 3 B). If
the vesicles enlarge as they acquire additional ACh, this
would also solve the problem of how the amount of ACh
required to produce the largest MEPCs could possibly be
packed into a vesicle of the size seen in the cytoplasm (Van
der Kloot, 1991b). The expanding vesicle model accounts
nicely for the properties of the MEPC.
Second-stage loading
The usual picture is that the vesicles are formed and receive
their quota of ACh in the cytoplasm. They then are fastened
at an active zone before they can be released. Doherty et al.
(1984, 1986) showed that this picture is incomplete. They
found that transitorily increasing the rate of quantal release
led to a transitory fall in MEPP amplitude. Their interpre-
tation is that the quanta receive part of their complement of
ACh while they are fastened at the active zones. During
stimulation quanta are released before they have time to
acquire their usual increment of ACh. In untreated prepa-
rations about 17% of the ACh is added to the stockpile of
quanta awaiting release. They estimated the size of this
stockpile at about 10,000, roughly the number of vesicles
positioned at the active zones. We have named the process
that adds more ACh to vesicles on the active zone second-
stage loading (Yu and Van der Kloot, 1991; Van der Kloot,
1991b).
An additional role for second-stage loading became ap-
parent when we discovered that after the ACh content of the
quanta had been experimentally increased, the process
could be reverted, so the quanta returned to normal size.
This could be done by activating protein kinase C, or by
exposing the preparation to micromolar concentrations of
nicotinic agonists (Van der Kloot, 1991a, 1993). These
treatments appear to turn off the production of additional
large quanta, but leave the terminal with a pre-existing store
of the large quanta. These must be released before all quanta
again are of normal size. We estimated the size of this
pre-existing store at 10,000-20,000 large quanta.
Further evidence for the role of second-stage loading
came from studies of the effects of inhibitors of active ACh
transport into isolated synaptic vesicles, like (-)-vesamicol
(Anderson et al., 1983; Prior et al., 1992). We found that
exposure to these inhibitors reduced the sizes of large
MEPCs and of MEPCs recorded when AChE was inhibited
(Yu and Van der Kloot, 1991; Van der Kloot et al., 1994;
Naves and Van der Kloot, manuscript in preparation). These
MEPCs can also be made smaller by treatment with hemi-
cholinium-3 (HC-3), which blocks choline uptake into
nerve terminals (Fig. 4 A). The changes are just like those
produced by 2 ,LM (-)-vesamicol (n = 6). Our interpreta-
tion is that lowering the cytoplasmic concentration of ACh
decreases second-stage loading, and therefore the quanta
become smaller (Fig. 4 B).
Second-stage loading can be followed by altering the
transmitter loaded into the vesicles. The false transmitter
acetylmonoethylcholine (AMECH), on average, opens end-
plate channels for only about half the duration they are
opened by ACh (Colquhoun et al., 1977; Large and Rang,
1978). Therefore, when a quantum contains AMECH the
MEPC decays roughly twice as fast as normally. The
AMECH is also less efficacious in opening endplate chan-
nels, so the amplitude of the MEPC is reduced. The nerve
terminals synthesize AMECH when the extracellular solu-
tion contains monoethylcholine (MECH). The MECH is
brought into the nerve terminal and acetylated to AMECH,
which is then stored in the synaptic vesicles.
In the following experiments all of the solutions con-
tained 10 ,uM neostigmine to minimize recycling of precur-
sor (Van der Kloot et al., 1995). Preparations were kept for
2 h in 200 mM Na gluconate solution containing 0.4 mM
MECH. They were then transferred to Ringer's, and a
junction was voltage clamped at a holding potential close to
that observed after both electrodes were inserted. Then the
solution was changed to Ringer's containing 10 ,uM choline
A. B.
10on
FIGURE 4 (A) Averaged MEPCs from a muscle pretreated in hypertonic
gluconate solution and the effects of HC-3. Recorded in Ringer's at -90
mV and 15°C. LargerMEPC, Average of 39 recorded in Ringer's. Smaller
MEPC, 103 recorded from the same junction after 48 min in 2 ,uM HC-3.
The HC-3 reduced the amplitude to 77% and the decay time to 80%.
Similar results were obtained in five additional experiments. (B) Diagram
of the proposed mechanism. Vesicles preloaded with ACh in the cytoplasm
attach at the active zones. While there they receive additional increments
of ACh. Release occurs through a pore between the vesicle interior and the
synaptic cleft.
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(CH). Both fMEPCs and the times at which they were
measured were recorded for many minutes. Fig. 5 A sum-
marizes one of these experiments. The bins are averages of
20 sequentially recorded fMEPCs. The fMEPCs had a
substantial variance, so that there was also considerable
variation in the averages. Nonetheless, there was a clear
upward trend in the averages. This suggests that MEPC size
was increasing. The distributions of fMEPCs in the first 100
recorded and the last 100 recorded, shown in the insert,
establish that there was a significant increase in quantal size
during the period of observation. We can roughly estimate
the number of quanta released during the period of obser-
vation. About 1100 MEPCs were recorded. By observing
the oscilloscope screen during the experiment we estimated
that at the very least we measured one-fifth of the MEPCs
released, so our estimate of the maximum number of quanta
released as the quantal size was almost doubled is 5500.
This contrasts with the estimate of about 300,000 vesicles
per junction, of which about 20,000 are positioned at the
active zones (Van der Kloot and Molgo, 1994). These
results were replicated twice more.
Similar experiments were done to follow the incorpora-
tion of AMECH into the quanta. After 2 h in 200 mM
sodium gluconate solution, the preparations were placed in
Ringer's and a junction was voltage clamped. Then the
solution was changed to Ringer's containing 0.4 mM
MECH and the MEPCs were recorded for a least 40 min.
Fig. 5 B shows that during the period of observation the
fMEPCs decreased in size. The insert shows that the first
100 and last 100 MEPCs recorded are significantly differ-
ent. Again the change occurred as the terminal released
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5000 or fewer vesicles (the observations were replicated in
two additional experiments).
Our picture is that a large number of vesicles containing
ACh are clustered in the cytoplasm. When positions at the
active zones become vacant, vesicles from the cytoplasm
attach. Once attached they acquire more ACh by second-
stage loading (Fig. 4 B). Usually second-stage loading in-
creases the ACh content by about 17%. After treatments that
increase quantal size, the ACh content can be increased by
100-300% (Van der Kloot, 1987, 1991b).
A model to account for the skew in quantal
size distributions
Second-stage loading seemed to offer a possible explanation
for the skewed distribution of quantal sizes. To test this
idea, we developed a Monte Carlo model that includes
second-stage loading. The vesicles are formed in the cyto-
plasm; the quantities of ACh they contain are normally
distributed. The vesicles then attach to release sites. While
on the active zone they continually acquire more ACh.
Release is random; there is no increase in the probability of
release when the vesicles contain more ACh. Three exam-
ples of the predictions of this model are shown in Fig. 6 A.
The distribution of MEPC sizes is no longer gaussian, as
shown by the upward curves in the plots of the data on a
probability axis. Like actual MEPC distributions, plots of
the logarithms of the sizes of the modeled quanta fall much
closer to normal probability distributions (Fig. 6 B).
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FIGURE 5 Experiments on the incorporation of different transmitters into quanta released from gluconate-treated muscles. All solutions contained 10 ,tM
neostigmine. (A) Muscle pretreated for 2 h in 200 mM gluconate + 0.4 mM MECH. In Ringer's, junction clamped at -88 mV. At time 0 10 ,uM CH was
added to the solution. (B) Muscle pretreated for 2 h in 200 mM gluconate. Ringer's, junction clamped at -90 mV. At time 0 400 ,uM MECH was added
to the solution. Further explanation in text.
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FIGURE 6 The distribution of quantal sizes predicted by a model in which the vesicles are first loaded with ACh in the cytoplasm, and then, after they
are attached at active zones, continue to acquire ACh at a steady rate until they are released by chance. Three rates of second-stage loading were modeled,
which brought the final ACh content to different proportions of the initial vesicle content. [1, To 117%; 0, to 200%; *, to 400%. (A) On a probability plot.
(B) The logarithms of the modeled sets are plotted to show that the distributions are more linear, as is the case with real data.
DISCUSSION AND CONCLUSIONS
The classical picture of ACh release at the neuromuscular
junction, in which the entire quantal content is dumped
instantaneously into the synaptic cleft, predicts rise times
faster than those observed at the frog neuromuscular junc-
tion. One possibility is that the rise times are not accurately
recorded. When an external electrode is used, the rise times
might be prolonged by the "compression artifact" (Katz and
Miledi, 1973). The artifact appears to be caused by the
external electrode pressing down on the nerve, which nar-
rows the synaptic cleft, thereby restricting ACh diffusion. In
the frog the artifact is small in normal circumstances, at
most about a 23% increase (Katz and Miledi, 1973). When
acetylcholinesterase is inhibited, compression can almost
double the rise time. We tried to avoid compression by
using electrodes with fine tips and by backing away the
electrode from the preparation once external MEPPs were
detected. In the frog the rise times measured with extracel-
lular electrode without obvious compression and with the
two-electrode voltage clamp are comparable (the literature
is summarized by Van der Kloot, 1995).
Stiles et al. (1995) explored the compression artifact at
the lizard neuromuscular junction, where the rise time is less
than 100 ,us. They showed that compression with an extra-
cellular electrode could double the rise time of MEPCs
measured with the two-electrode voltage clamp, even
though acetylcholinesterase was not inhibited. This shows
clearly that caution is required in interpreting the measure-
ments with external electrodes. This is especially true be-
cause the external electrodes record an unexpectedly large
proportion of the MEPPs at junction (references in Van der
Kloot, 1996), which suggests that we really do not under-
stand the equivalent circuit for extracellular recording. We
think the weight of evidence at the frog neuromuscular
junction suggests that the rise times are slower than pre-
dicted by the classical model. The discrepancy is especially
striking for the most slowly rising miniatures in each data
set.
After quantal size has been increased, the decay times of
many of the MEPCs are also strikingly longer than pre-
dicted by the model. To produce such long MEPCs, end-
plate channels must continue to open for as long as 10 ms
after the beginning of the signal (Van der Kloot, 1991b,
figure 20). In untreated preparations, there are almost al-
ways some MEPCs that are notably long. The present re-
sults show that in untreated preparations the variance of the
decay times is substantially greater than that predicted by
the model.
One way to account for the slower than predicted rise
times and the longer than predicted durations is by modi-
fying the model so that the ACh is released through a pore
extending from the interior of the synaptic vesicle to the
synaptic cleft. However, even with this modification the
model does not predict the observed correlation between
MEPC amplitude and decay time. If we modify the model
by assuming that as more ACh is added the volume of the
vesicles increases, then the predictions of the model are
much more like real MEPCs. An increase in vesicle size
would also solve the problem of how the quantity of ACh
released in the largest quanta could be packed into a vesicle
of usual size (Van der Kloot, 1991b) and would not require
the ACh transporter to work against an increasing gradient
of ACh across the vesicular membrane.
However, the sizes of the vesicles in the nerve terminal
before and after treatments that increase quantal size are
indistinguishable (Spielholz and Van der Kloot, 1987). This
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does not disprove the hypothesis, because there is substan-
tial evidence that some of the ACh is added to the quanta by
second-stage loading, presumably when the vesicles are at
the active zones (Doherty et al., 1984, 1986; Yu and Van der
Kloot, 1991; Van der Kloot, 1993). The results with MECH
clearly show how important second-stage loading is after
quantal size has been increased. Therefore our hypothesis is
that when quantal size has been enlarged, some of the
vesicles at the active zone should be appreciably larger than
those in the cytoplasm. This hypothesis can be tested.
Second-stage loading can also account nicely for the
skew to the right seen in distributions of quantal sizes and
decay times. It also accounts for the numerous observations
showing that newly synthesized ACh is released preferen-
tially (references in Tauc, 1982). Our model of second-stage
loading suggests that this process accounts for the skew that
is commonly observed in the distribution of miniature am-
plitudes, sizes, and decay times. This model can be tested
further by experiments in which nerve stimulation is used to
rapidly release many of the quanta at the active zones.
The evidence presented in this paper for second-stage
loading and the correlation between amplitude and decay
time comes largely from preparations in which quantal size
has been increased. However, similar results are obtained
from untreated junctions when the AChE is inhibited
(Naves and Van der Kloot, manuscript in preparation). (The
inhibition of the AChE probably allows the tail of ACh
release to open channels rather than be destroyed before
reaching the endplate; see Van der Kloot et al., 1994, figure
11.)
Obviously at present we have little idea of how applicable
these ideas are to transmission at central synapses. They are
attractive because it seems that the hypothesis that quantal
responses at central synapses have almost no variance ap-
pears to be incorrect (Walmsey, 1995), and because the size
of the quantal responses is skewed to the right, as they are
for MEPCs (Bekkers et al., 1991; reviewed by Edwards,
1995). The skew is also apparent at crayfish and Droso-
philia neuromuscular junctions (Cooper et al., 1995).
To summarize, we suggest that a number of features of
MEPCs can be accounted for by modifying the classical
model, supposing that release is through a pore from a
vesicle whose size varies with its ACh content. Other ex-
planations for the observed features of the MEPCs are
surely possible. The present hypothesis can be tested exper-
imentally by measuring vesicle sizes at the active zones.
Release by way of a pore also may help to account for the
substantial body of data suggesting that at the neuromuscu-
lar junction in some conditions the membrane of the vesicle
ultimately fuses into the terminal membrane, whereas in
other instances the vesicle releases its contents and returns
directly to the cytoplasm (Colasante and Pecot-
Dechavassine, 1995; reviewed by Van der Kloot and
Molg6, 1994). In some circumstances the pore may open
and then close, so that the empty vesicle is restored to the
cytoplasm. In other circumstances the pore may open and
continue to expand until the vesicle membrane is fused to
the terminal membrane. If these two modes of release exist,
it is conceivable that the rise times of MEPCs will vary
according to the mode employed.
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